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Background. Literature regarding the inﬂuence of age/sex on mortality trends for acute myocardial infarction (AMI) hospitaliza-
tions is limited to hospitals participating in voluntary AMI registries. Objective. Evaluate the impact of age and sex on in-hospital
AMI mortality using a nationally representative hospital sample. Methods. Secondary data analysis using AMI hospitalizations
identiﬁed from the Nationwide-Inpatient-Sample (NIS). Descriptive and Cox proportional hazards analysis explored mortality
trends by age and sex from 1997–2006 while adjusting for the inﬂuence of, demographics, co-morbidity, length of hospital stay
and hospital characteristics. Results. From 1997–2006, in-hospital AMI mortality rates decreased across time in all subgroups
(P<. 001), except for males aged <55 years. The greatest decline was observed in females aged <55 years, compared to similarly
aged males, mortality outcomes were poorer in 1997-1998 (RR 1.47, 95% CI = 1.30–1.66), when compared with 2005-2006
(RR 1.03, 95% CI = 0.90–1.18), adjusted P value for trend demonstrated a statistically signiﬁcant decline in the relative AMI
mortality risk for females when compared with males (<0.001). Conclusion. Over the last decade, in-hospital AMI mortality rates
d e c l i n e df o re v e r ya g e / s e xg r o u pe x c e p tm a l e s<55 years. While AMI female-male mortality disparity has narrowed, some room
for improvement remains.
1.Introduction
Cardiovascular disease is the leading cause of death and
disability in the United States, accounting for the underlying
cause of death for about 1 in 2.8 deaths in the United States
[1, 2]. Fortunately, observations over the last 20 years suggest
thatdeathratesfollowinganindexAMIaresteadilydeclining
[3–7], largely due to eﬀective drugs and revascularization
procedures [8, 9]. Recent evidence also indicates that the
hitherto reported sex disparity: higher mortality rates after
AMI in young females relative to their similarly aged male
counterparts may be diminishing [10–13].
However, many of the aforementioned studies obtained
data from registries comprising hospitals that voluntarily
signed up for participation or focused only on a spe-
ciﬁc age group (e.g., >65 years) and thus may not be
broadly representative. Indeed, hospitals participating in
these registries tend to diﬀer from nonparticipating hospitals
by being larger, more procedure-oriented centers with a
major interest in the improvement of quality metrics and
processes [14].
Using widely representative hospital administrative data,
the main objective of this study was to assess trends in age-
andsex-speciﬁcin-hospitalmortalityafterAMIintheUnited
States. A secondary objective was to examine recent nation-
wide patterns in the use of common procedures during AMI
hospitalization by sex and age.
2. Methods
Data were obtained from the Nationwide Inpatient Sam-
ple (NIS), developed as part of the Healthcare Cost
and Utilization Project (HCUP), a Federal-State-Industry2 Cardiology Research and Practice
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Figure 1: In-hospital AMI mortality rate and relative mortality trend (female versus male) by NIS year for age <55 years.
partnership sponsored by the Agency for Healthcare
Research and Qual ity (AHRQ) [15]. NIS is designed to
approximate a stratiﬁed 20% sample of all non-Federal,
short-term, general, and specialty hospitals serving adults
in the United States. The sampling strategy selects hospitals
within states that have State Inpatient Databases (SID)
according to deﬁned strata based on ownership, bed size,
teaching status, urban/rural location, and region. All dis-
charges from sampled hospitals for the calendar year are
then selected for inclusion into NIS. To allow for national
estimate extrapolation, both hospital and discharge weights
wereprovided.DetailedinformationonthedesignoftheNIS
is available at http://www.hcup-us.ahrq.gov. From 1997 to
2006, NIS captured discharge-level information on primary
and secondary diagnoses and procedures, discharge vital
status, and demographics on discharges per year. Data
elements that could directly or indirectly identify individuals
were excluded; we thus considered all discharges to be
independent. The unit of analysis was the discharge rather
than the individual. A unique hospital iden tiﬁer allows for
linkage of discharge data to an NIS data set with hospital
characteristics.
To analyze myocardial infarction hospitalizations, we
identiﬁed all discharges for which an ICD9-CM code of
410.xx (acute myocardial infarction including STEMI and
NSTEMI) was listed as the primary diagnosis. This approach
has been utilized by other studies and was taken to speciﬁ-
cally focus on patients who presented with acute myocardial
infarction and not those patients who had AMI secondary to
other conditions like, surgery, hypotension, or other events
posthospitalization.Totalnumbersofmyocardialinfarctions
wereobtained bysumming acrosscodes. Similarly procedure
c o d e sf o rt h et e nm o s tc o m m o np r o c e d u r e sw e r ea l s o
identiﬁed using the reported ICD9-CM code. We accounted
for procedure code changes that occurred in 2005 while
extracting the data (single vessel percutaneous transluminal
coronary angioplasty [PTCA] or coronary atherectomy with
and without a thrombolytic agent; 36.01 and 36.02). This
secondary data analysis study was approved by the Charles
R Drew University of Medicine and Science IRB.
3.StatisticalAnalyses
We compared trends in-hospital AMI mortality in males and
females before and after adjustment for covariates. Analyses
werestratiﬁedbyagegroupincluding<55,55–64,65–74,75–
84, and >84 years. The following demographic and clinical
characteristics were adjusted for: age, race (white, black,
other, and unknown), primary payer (Medicare, Medicaid,
private, and other), medical comorbidity, and number of
procedures performed as ordinal variables. In addition,
the following hospital characteristics were also adjusted for
region (NE, MW, S, and W), bedsize (small, medium, and
large), AMI volume by quartile and location/teaching status
(rural, urban nonteaching, and urban teaching). The time
variable was grouped into ﬁve 2-year intervals from 1997-
1998 to 2005-2006.
The number and severity of comorbid conditions were
assessed using the Charlson’s co-morbidity index (CCI) [16–
18]. We used the modiﬁed version of the CCI based on the
recent work by Quan et al. [19]. The CCI is a weighted score
composed of 17 comorbid conditions including congestive
heart failure, myocardial infarction, chronic pulmonary dis-
ease, cerebrovascular disease, hemiplegia or paraplegia,
dementia, diabetes without complications, diabetes with
complication, malignancy, metastatic solid tumor, mild liver
disease, moderate or severe liver disease, peptic ulcer disease,
peripheral vascular disease, rheumatologic disease, renal
disease, and AIDS.
For the purpose of the multivariate Cox regression anal-
ysis, CCI was grouped into 4 categories including a CCI of
1, 2, 3, or 4 or greater. As an additional strategy, the rela-
tionship between comorbidities and in-hospital mortality
after MI was modeled by including the individual comorbid
conditions in the models as separate variables. However,
this latter approach gave similar results as when using CCI
as a categorical variable and is therefore not reported. In
addition, we also adjusted for the following three additional
co-morbid conditions that were not components of the CCI:
1.) valvular disease (ICD9 code: 0932, 394, 395, 396, 397,
424, 7463, 7464, 7465, 7466, V422, and V433), hypertensionCardiology Research and Practice 3
Table 1: Descriptive summary statistics by NIS year and sex: acute MI hospitalizations, age <65 years.
Year 1997-1998 Year 1999-2000 Year 2001-2002 Year 2003-2004 Year 2005-2006
Male Female Male Female Male Female Male Female Male Female
Demographic characteristics N =
418,685
N =
150,983
N =
415,073
N =
154,638
N =
431,435
N =
164,923
N =
417,284
N =
161,420
N =
399,493
N =
155,542
Age†, mean 52.8 54.4 52.8 54.1 52.9 54.0 53.0 54.0 53.0 54.0
White 63.2% 59.5% 61.0% 56.4% 54.4% 50.4% 53.0% 49.4% 54.9% 50.3%
Black 6.2% 11.2% 6.1% 11.1% 6.2% 11.2% 6.5% 11.6% 5.9% 10.9%
∗Other Race† 7.5% 6.5% 8.2% 7.5% 9.6% 8.6% 10.5% 9.9% 10.7% 10.2%
Unknown Race† 23.1% 22.8% 24.7% 24.9% 29.9% 29.8% 30.0% 29.1% 28.5% 28.6%
Primary payer
Medicare 9.9% 12.5% 10.9% 14.3% 11.3% 15.0% 11.6% 16.3% 11.9% 17.1%
Medicaid 6.8% 14.0% 7.2% 14.5% 7.6% 14.6% 8.4% 15.7% 8.6% 15.4%
Private 69.3% 60.1% 68.0% 58.1% 66.5% 57.1% 63.4% 52.9% 61.3% 51.1%
∗∗Other 14.0% 13.4% 13.8% 13.0% 14.6% 13.4% 16.7% 15.1% 18.3% 16.4%
Charlson’s comorbidity index
1 58.7% 43.0% 57.0% 40.6% 55.9% 40.4% 53.4% 37.6% 51.9% 36.3%
2 26.0% 30.5% 26.4% 30.8% 26.6% 30.5% 27.4% 30.6% 27.7% 30.7%
3 9.2% 14.8% 9.6% 15.8% 9.8% 15.4% 10.8% 16.5% 11.0% 16.5%
≥4 6.1% 11.7% 7.0% 12.7% 7.7% 13.7% 8.3% 15.3% 9.4% 16.6%
Cardiovascular Comorbid
condition
Atrial ﬁbrillation/ﬂutter 6.3% 5.8% 6.1% 5.4% 6.5% 5.6% 6.7% 6.0% 6.9% 6.1%
Cerebrovascular disease 2.2% 3.5% 2.3% 3.5% 2.2% 3.6% 2.3% 3.6% 2.3% 3.6%
Chronic pulmonary disease 11.5% 16.2% 12.1% 18.1% 12.6% 19.1% 13.6% 21.1% 14.2% 22.3%
Congestive heart failure 15.4% 22.5% 15.1% 22.3% 15.1% 21.8% 16.3% 23.8% 16.2% 23.5%
Diabetes with complication 2.7% 5.9% 2.9% 6.2% 3.1% 6.1% 3.1% 6.4% 3.0% 5.8%
Diabetes without complication 17.8% 27.1% 19.6% 28.2% 20.9% 28.5% 22.0% 30.1% 22.8% 31.2%
Hypertension 40.8% 48.4% 43.6% 51.9% 47.6% 55.3% 52.0% 58.5% 56.2% 61.6%
Peripheral vascular disease 3.6% 4.7% 4.0% 5.2% 4.0% 5.7% 4.6% 6.0% 4.9% 6.3%
Renal disease 2.5% 4.5% 3.1% 5.7% 3.6% 6.2% 3.9% 6.9% 5.7% 8.7%
Valvular disease 5.9% 9.6% 5.0% 8.3% 5.1% 8.4% 5.4% 8.4% 5.8% 9.4%
Number of procedures
performed
0-1
2-3 26.1% 27.4% 21.8% 24.4% 18.6% 22.1% 15.6% 20.3% 12.5% 17.9%
4-5 27.5% 24.7% 25.9% 24.3% 26.3% 24.4% 26.2% 24.2% 17.6% 18.2%
≥6 18.8% 17.6% 26.3% 22.5% 33.3% 28.3% 40.4% 33.6% 55.8% 45.2%
Type of procedure performed
3722/8856/8853—Left Heart
cardiac catheterization/coronary
arteriography/angiocardiography
of left heart structures
60.82% 56.94% 63.39% 58.63% 68.20% 63.57% 73.42% 67.29% 77.08% 71.52%
3601 and 3602—single-vessel
PTCA or coronary atherectomy
with or without mention of
thrombolytic agent
32.53% 28.16% 35.08% 29.56% 40.80% 33.26% 44.79% 36.10% 42.20% 33.76%
3606/3607—insertion of
nondrug/ drug-eluting coronary
artery stent(s)
25.13% 20.71% 34.81% 28.28% 42.30% 33.46% 48.55% 37.95% 54.45% 42.50%4 Cardiology Research and Practice
Table 1: Continued.
Year 1997-1998 Year 1999-2000 Year 2001-2002 Year 2003-2004 Year 2005-2006
Male Female Male Female Male Female Male Female Male Female
9920—injection or infusion of
platelet inhibitor 0.6% 0.4% 14.6% 11.5% 23.7% 18.9% 27.6% 21.5% 25.6% 20.1%
3961—extracorporeal circulation
auxiliary to open heart surgery 10.8% 8.7% 9.9% 7.7% 9.5% 7.1% 9.3% 6.7% 8.2% 5.8%
3615—single internal
mammary-coronary Artery
bypass
9.6% 7.3% 9.7% 7.2% 10.1% 7.3% 9.9% 7.0% 9.7% 6.8%
8872†—diagnostic ultrasound of
heart (Echo, TEE) 6.0% 6.4% 4.7% 5.1% 4.2% 4.6% 5.2% 5.7% 5.0% 5.0%
No procedure performed 18.4% 20.8% 18.1% 20.7% 15.8% 18.8% 13.1% 16.1% 10.5% 13.9%
LOS, median days 3.2 3.5 2.8 3.1 2.6 2.9 2.6 2.8 2.4 2.7
∗includes Hispanic, Asian Paciﬁc Islander, Native American, and other
∗∗includes no pay, self pay, and other
†indicates P>. 05 (not signiﬁcant) as follows; (a) Age for all year groups, (b) Other race: Year 2003-2004 and Year 2005-2006, (c) Unknown race for all year
groups, and (d) Procedure 8872 for all year groups.
(ICD9codes401–405,6420,6421,6422,and6427),andatrial
ﬁbrilation (ICD9 code 4273).
We computed the descriptive summary statistics for
demographic/clinical characteristics by year, sex, and age
group. To simplify the presentation, the descriptive results
were reported separately in those younger than 65 years
and in those aged 65 years or older. Common in-hospital
procedure rates and median length of hospital stay (LOS)
were also descriptively evaluated using ICD9-CM codes
described earlier.
Unadjusted weighted proportions of MI hospitalizations
that resulted in death were computed by year, sex, and age
group. Results were plotted in order to visually check for
any important trends and/or interaction eﬀects in the data.
For each sex/age group combination, trends across time
were assessed using Cox regression analysis models while
adjusting for in-hospital mortality using a composite of
the encounter discharge disposition data and reported LOS
for incident and censored mortality occurrence. For each
age group, the unadjusted relationship between sex and in-
hospital mortality across time was summarized using hazard
ratios.
To evaluate the relationship between sex and in-hospital
mortality across time while simultaneously adjusting for
all of the above covariates, we used the multivariate Cox
proportional hazards regression model and accounted for
appropriate weighting, clustering, and stratiﬁcation required
for the complex NIS survey design. Adjusted hazard ratio
e s t i m a t e sw e r ec o m p u t e di ne a c ha g eg r o u ps e p a r a t e l y .W e
used a series of nested models as a way of identifying the
variables that accounted for any observed trends in the
unadjusted analyses. All data analyses were conducted using
SAS (version 9.1; SAS Institute Inc, Cary, NC). Statistical
hypotheses were tested using P<. 05 as the level of statistical
signiﬁcance.
4. Results
Tables 1 and 2 attached show the descriptive summary statis-
tics in persons aged less than 65 years and in persons aged
65 years or older, respectively. AMI encounter cases among
males and females aged <65 years and ≥65 years remained
approximately similar from 1997 to 2006 though trends in
other races demonstrated an increase while Caucasian AMI
incidence declined slightly. Median, LOS decreased for all
age and sex groups from 1997 to 2006 though females aged
<65 tended to have a greater in-hospital LOS than males in
this same age group. Among all age groups, Medicare and
Medicaid coverage for AMI encounters also demonstrated
a slight increase when compared from 1997 to 2006. The
burden of multiple medical co-morbidity (CCI ≥ 4) also
demonstrated an increase for all age groups from 1997 to
2006. Hypertension and diabetes (with or without compli-
cations) accounted for the largest associated cardiovascular
co-morbidity among AMI encounters for all age groups with
lager increases observed for both males and females of all
age groups. Among all age and sex groups AMI encounters
with no recorded procedures declined from 1997 to 2006.
The overall incidence of left heart cardiac catheteriza-
tion/coronary arteriography/angiocardiography of left heart
structures increased for all age groups though the trend
demonstrated greater procedure occurrence among males
than females.
Tables 3 and 4 demonstrates the crude (unadjusted)
age and sex AMI mortality trends from 1997 to 2006.
AMI mortality was mostly higher among females when
compared with males of younger age groups. A statistically
signiﬁcant decline in AMI mortality was also observed for
all age and sex groups except for males aged <55 years for
the evaluation period. A linear decline in AMI mortality
disparity was observed with increasing age with the mostCardiology Research and Practice 5
Table 2: Descriptive summary statistics by NIS year and sex: acute MI hospitalizations, age ≥65 years.
Year 1997-1998 Year 1999-2000 Year 2001-2002 Year 2003-2004 Year 2005-2006
Male Female Male Female Male Female Male Female Male Female
Demographic
characteristics
N =
471,238
N =
436,874
N =
469,844
N =
451,786
N =
473,381
N =
465,064
N =
436,054
N =
428,289
N =
396,588
N =
382,075
Age†, mean 75.4 78.2 75.9 78.8 76.3 79.2 76.5 79.4 76.6 79.7
White 70.6% 68.6% 68.3% 66.1% 62.3% 60.5% 60.3% 58.8% 61.8% 60.2%
Black 3.9% 5.4% 4.0% 5.6% 3.9% 5.4% 4.4% 6.2% 3.8% 5.6%
∗Other race 5.8% 5.4% 6.5% 6.1% 7.3% 6.8% 8.5% 8.1% 8.5% 8.0%
Unknown race† 19.6% 20.6% 21.2% 22.2% 26.6% 27.3% 26.7% 26.9% 25.9% 26.2%
Primary payer
Medicare 84.1% 88.1% 85.6% 89.7% 86.8% 90.6% 88.4% 91.7% 88.0% 91.9%
Medicaid 1.0% 1.4% 1.2% 1.6% 1.2% 1.5% 1.1% 1.6% 1.0% 1.4%
Private 13.4% 9.5% 11.6% 7.6% 10.4% 6.9% 8.9% 5.7% 9.2% 5.7%
∗∗Other 1.6% 1.0% 1.7% 1.2% 1.5% 1.0% 1.6% 1.1% 1.8% 1.0%
Charlson’s comorbidity
index
1 30.8% 26.8% 28.9% 25.1% 28.2% 24.3% 26.1% 22.0% 24.4% 20.8%
2 31.3% 34.2% 31.1% 33.6% 29.9% 32.7% 29.7% 32.2% 27.0% 29.8%
3 20.1% 22.5% 20.8% 23.4% 21.1% 23.5% 21.8% 24.5% 20.4% 23.3%
≥4 17.8% 16.5% 19.2% 17.9% 20.8% 19.5% 22.4% 21.2% 28.2% 26.0%
Cardiovascular Comorbid
condition
Atrial atrial ﬁbrillation
/ﬂutter† 22.2% 21.6% 22.7% 22.0% 23.2% 23.0% 23.8% 23.2% 24.4% 24.6%
Cerebrovascular disease 7.4% 8.2% 7.4% 8.4% 7.0% 8.1% 7.0% 8.2% 6.9% 8.2%
Chronic pulmonary disease 21.4% 17.6% 23.3% 19.5% 24.3% 21.6% 25.0% 23.4% 26.1% 25.6%
Congestive heart failure 38.9% 46.3% 39.2% 46.6% 39.0% 46.1% 40.7% 48.1% 40.6% 48.0%
Diabetes with
complication† 3.4% 3.8% 3.7% 4.0% 3.9% 4.0% 4.2% 4.0% 4.1% 4.0%
Diabetes without
complication 23.2% 25.8% 24.5% 26.8% 25.6% 26.9% 26.6% 27.8% 27.3% 27.8%
Hypertension 45.4% 53.9% 49.7% 57.5% 54.3% 61.4% 59.0% 65.1% 63.5% 69.0%
Peripheral vascular disease 9.0% 7.2% 9.6% 7.7% 10.1% 8.3% 10.8% 9.0% 11.6% 9.6%
Renal disease 6.7% 5.6% 7.7% 6.5% 9.2% 7.6% 10.5% 8.7% 17.8% 14.2%
Valvular disease 15.5% 18.8% 13.3% 17.2% 14.1% 17.7% 14.8% 18.3% 16.8% 20.5%
Number of procedures
performed
0-1 41.6% 49.0% 40.9% 49.6% 38.0% 47.2% 35.4% 44.8% 32.4% 42.5%
2-3 23.0% 22.0% 20.8% 19.9% 18.4% 18.3% 17.2% 17.8% 15.1% 15.9%
4-5 18.0% 15.4% 17.9% 14.9% 18.0% 15.0% 18.2% 15.5% 14.2% 12.6%
≥6 17.5% 13.7% 20.5% 15.7% 25.6% 19.5% 29.3% 22.0% 38.3% 28.9%
Type of procedure
performed
3722/8856/8853—left heart
cardiac
Catheterization/Coronary
Arteriogra-
phy/angiocardiography of
left heart structures
42.46% 34.48% 43.52% 34.84% 47.73% 38.52% 50.35% 40.62% 53.86% 43.90%6 Cardiology Research and Practice
Table 2: Continued.
Year 1997-1998 Year 1999-2000 Year 2001-2002 Year 2003-2004 Year 2005-2006
Male Female Male Female Male Female Male Female Male Female
3601 and 3602—single
vessel PTCA or coronary
Atherectomy with or
without mention of
thrombolytic agent
16.88% 14.38% 18.03% 14.81% 21.79% 17.59% 23.97% 19.15% 23.44% 18.71%
3606/3607—insertion of
nondrug/Drug-eluting
coronary artery stent(s)
12.76% 10.34% 17.80% 14.39% 22.47% 18.05% 26.06% 20.67% 30.52% 24.12%
9920†—injection or
infusion of platelet
inhibitor
0.3% 0.2% 7.4% 5.8% 13.3% 10.0% 14.7% 11.3% 14.3% 10.7%
3961—extracorporeal
circulation auxiliary to
open heart surgery
10.3% 6.9% 9.2% 5.5% 8.8% 5.4% 8.6% 4.9% 7.8% 4.4%
3615—single internal
mammary-coronary artery
bypass
8.4% 4.8% 8.5% 4.7% 8.9% 5.0% 8.6% 4.6% 9.1% 4.8%
8872†—diagnostic
ultrasound of heart (Echo,
TEE)
6.8% 7.5% 5.8% 6.0% 5.2% 5.2% 6.0% 6.1% 6.1% 6.0%
No procedure performed 31.1% 37.5% 31.1% 38.5% 29.4% 37.1% 26.8% 34.4% 24.4% 32.5%
LOS, median days 4.3 4.6 3.9 4.3 3.7 4.1 3.7 4.0 3.5 3.8
∗includes Hispanic, Asian Paciﬁc Islander, Native American, and other
∗∗includes no pay, self-pay, and other
†indicates P>. 05 (not signiﬁcant) as follows: (a) Age for all year groups, (b) Unknown race: Year 2001-2002, Year 2003-2004, and Year 2005-2006, (c)
Procedure 9920 for Year 1997-1998, (d) Procedure 8872 for all year groups, (e) Diabetes with complication Year 2001-2002 and Year 2005-2006 (f) Atrialﬁ b
Year 2001-2002 and Year 2005-2006.
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Figure 2: In-hospital AMI mortality rate and relative mortality trend (female versus male) by NIS year for age 55–64 years.
marked diﬀerence observed among females age <55 years.
In addition, in the younger age groups, mortality rates
decreased at a faster rate in females than in males. For
example, in the age group 55–64 years, the in-hospital
mortality decreased by 30% in 2005-2006 relative to 1997-
1998 in females and only by 17% in males. Similarly, in the
age group <55 years in-hospital mortality decreased by 35%
in 2005-2006 relative to 1997-1998 in females and did not
signiﬁcantly decrease in males. Figures 1,2,3,4 and 5 presents
age group-speciﬁc trends in male and female AMI mortality
for the evaluated year blocks.
Table 5 presents the unadjusted and adjusted female to
male relative risk (RR) for in-hospital mortality after acute
MI. In MODEL I (unadjusted), the RR diﬀerence between
females and males was largest in the younger age groups with
thediﬀerencenarrowingwithincreasingage.Inaddition,theCardiology Research and Practice 7
Table 3: In-hospital AMI mortality rate by NIS year, sex, and age group.
Age group NIS year % Mortality (male) SE % Mortality (female) SE
<55 yrs
1997-1998 1.78% 0.07% 3.50% 0.17%
1999-2000 1.91% 0.07% 3.33% 0.15%
2001-2002 1.83% 0.07% 2.87% 0.14%
2003-2004 1.74% 0.08% 2.89% 0.14%
2005-2006 1.76% 0.07% 2.32% 0.12%
55–64 yrs
1997-1998 3.81% 0.11% 5.80% 0.19%
1999-2000 3.84% 0.11% 5.23% 0.18%
2001-2002 3.61% 0.11% 4.97% 0.17%
2003-2004 3.32% 0.11% 4.59% 0.18%
2005-2006 3.17% 0.10% 4.14% 0.17%
65–74 yrs
1997-1998 7.41% 0.14% 8.70% 0.18%
1999-2000 7.25% 0.14% 8.40% 0.17%
2001-2002 6.73% 0.14% 7.53% 0.19%
2003-2004 6.19% 0.15% 7.00% 0.18%
2005-2006 5.42% 0.15% 6.25% 0.17%
75–84 yrs
1997-1998 12.64% 0.19% 13.29% 0.19%
1999-2000 12.31% 0.21% 12.58% 0.20%
2001-2002 11.28% 0.20% 11.76% 0.19%
2003-2004 10.72% 0.19% 10.83% 0.19%
2005-2006 9.64% 0.20% 9.28% 0.19%
>84 yrs
1997-1998 20.27% 0.40% 20.03% 0.32%
1999-2000 19.59% 0.38% 18.45% 0.27%
2001-2002 18.30% 0.36% 17.29% 0.27%
2003-2004 16.24% 0.33% 15.77% 0.26%
2005-2006 14.86% 0.32% 13.93% 0.24%
Table 4: In-hospital AMI mortality change across time (1997–2006).
Sex Age group HR change (2005-2006 versus 1997-1998) 95% CI P value for trend
Lower Upper
Males
<55 yrs 0.99 0.88 1.11 0.3690
55–64 yrs 0.83 0.76 0.90 <.0001
65–74 yrs 0.72 0.67 0.77 <.0001
75–84 yrs 0.74 0.70 0.78 <.0001
>84 yrs 0.69 0.64 0.74 <.0001
Females
<55 yrs 0.65 0.57 0.75 <.0001
55–64 yrs 0.70 0.63 0.78 <.0001
65–74 yrs 0.70 0.65 0.75 <.0001
75–84 yrs 0.67 0.63 0.70 <.0001
>84 yrs 0.65 0.61 0.68 <.0001
RR in the younger age groups were larger in the early time
points and became smaller at latter time points, indicating
that the diﬀerences in mortality became less pronounced at
latter times (sex by time interaction: P<. 05 for age groups
<65 years). After adjustment for demographic and clinical
characteristics (MODEL II), the diﬀerences in mortality
rates in the younger age groups became less pronounced
as evidenced by the smaller RR that were closer to 1 than
in the unadjusted analysis. The changes in the RR after
the adjustment appear to be uniform across all study years.
The sex diﬀerences at earlier times, however, remained
statistically signiﬁcant even after the adjustment, implying
that the covariates in our model did not fully account for
the observed diﬀerences between younger males and females
at earlier times. In addition, the excess mortality in females
relative to males remained higher at earlier time points8 Cardiology Research and Practice
Table 5: Univariate (unadjusted) and multivariable (adjusted) Cox regression analysis models for in-hospital AMI mortality NIS year and
age group: female versus male (male = reference).
Year 1997-1998 Year 1999-2000 Year 2001-2002 Year 2003-2004 Year 2005-2006
P value
for
sex-time
trend
P value
for sex-
time-
age
trend
Age Group RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI
MODEL I: Unadjusted
<55 yrs 1.81 1.62–2.03 1.60 1.43–1.79 1.43 1.28–1.60 1.52 1.35–1.71 1.23 1.08–1.39 <.001
P<. 001
55–64 yrs 1.38 1.27–1.49 1.25 1.15–1.35 1.24 1.14–1.35 1.26 1.15–1.37 1.21 1.09–1.33 .131
65–74 yrs 1.11 1.06–1.17 1.11 1.05–1.17 1.06 1.00–1.13 1.08 1.02–1.14 1.09 1.02–1.17 .506
75–84 yrs 1.03 0.99–1.07 1.02 0.98–1.06 1.03 0.99–1.08 1.00 0.96–1.05 0.98 0.93–1.04 .188
>84 yrs 0.98 0.94–1.04 0.93 0.88–0.98 0.95 0.90–1.00 1.01 0.96–1.06 0.97 0.92–1.02 .760
MODEL II: Adjusted for demographic and clinical characteristics
<55 yrs 1.47 1.31–1.67 1.37 1.21–1.54 1.16 1.03–1.32 1.26 1.11–1.43 1.03 0.90–1.18 <.001
P<. 001
55–64 yrs 1.23 1.13–1.34 1.10 1.01–1.21 1.08 1.00–1.18 1.08 0.98–1.18 1.06 0.95–1.17 .010
65–74 yrs 1.09 1.03-1.15 1.09 1.03–1.15 1.04 0.98–1.10 1.03 0.98–1.10 1.06 0.99–1.14 .294
75–84 yrs 1.05 1.00–1.09 1.03 0.99–1.08 1.04 0.99–1.09 1.01 0.96–1.05 0.99 0.94–1.04 .047
>84 yrs 1.00 0.95–1.05 0.94 0.90–0.99 0.95 0.90–1.00 0.99 0.95–1.04 0.95 0.90–1.00 .620
MODEL III: Adjusted for demographic, clinical characteristics and hospital factors
<55 yrs 1.47 1.30–1.66 1.37 1.21–1.55 1.16 1.03–1.32 1.26 1.11–1.43 1.03 0.90–1.18 <.001
P<. 001
55–64 yrs 1.24 1.14–1.34 1.10 1.01–1.21 1.08 0.99–1.18 1.08 0.98–1.19 1.06 0.95–1.17 .010
65–74 yrs 1.10 1.04–1.16 1.09 1.03–1.15 1.04 0.98–1.10 1.04 0.98–1.10 1.06 0.99–1.14 .248
75–84 yrs 1.05 1.01–1.09 1.03 0.99–1.08 1.04 0.99–1.09 1.01 0.96–1.06 0.99 0.93–1.04 .043
>84 yrs 1.00 0.95–1.05 0.95 0.90–0.99 0.95 0.90–1.00 0.99 0.95–1.04 0.95 0.90–1.00 .533
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Figure 3: In-hospital AMI mortality rate and relative mortality trend (female versus male) by NIS year for age 65–74 years.
relative to latter time points, hence the adjustment did not
account for the diﬀerential sex eﬀect across time. Additional
adjustment for hospital characteristics had a negligible eﬀect
on the ﬁnal results (MODEL III). Figures 1–5 present age
group-speciﬁc AMI relative mortality risk trends in females
compared with males (reference) AMI incidence for the
evaluated year blocks.
5. Discussion
Our results demonstrate that in-hospital mortality after AMI
decreased signiﬁcantly across time in all gender and age
subgroups from 1997 to 2006 in the United States. Further-
more, we conﬁrmed results from studies based on data from
registries containing voluntarily participating hospitals thatCardiology Research and Practice 9
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Figure 5: In-hospital AMI mortality rate and relative mortality trend (female versus male) by NIS year for age >84 years.
a significant decline has occurred in in-hospital mortality
among young and middle-aged females in the past decade
[10]. These changes in mortality after AMI in young and
middle-aged females greatly narrowed the prevailing dis-
parity but by no means eliminated it, indicating that there
remains some room for improvement.
Our results also demonstrate that crude in-hospital pro-
c e d u r er a t e sw e r em u c hl e s si na g eg r o u pm a t c h e df e m a l e s
than in their male counterpart, particularly for revascular-
ization procedures though further studies are required to
understand these observations in detail. Previous studies
have reported that less aggressive therapy including the use
of acute reperfusion therapies like percutaneous coronary
intervention (PCI) may be contributory to poorer outcomes
observed in young and middle-aged females when com-
pared with their male counterparts [20–24]. We found that
although crude in-hospital procedure rates were performed
with lesser frequency among females, particularly revascu-
larization procedures, the sex diﬀerential in crude procedure
rates observed in our study did not adequately account for
the observed mortality disparity.
Of note, we did observe that among females aged <65
years the crude multiple co-morbidity rates (>3 CCI) was
higher for females compared with males. It is conceivable
that additional co-morbidity especially presence/severity of
cardiovascular risk factors [25], may inﬂuence initiation of
aggressive revascularization therapy as well as worsen clinical
outcomes in AMI patients.
Thechangingco-morbidityandcardio-metabolicdisease
risk proﬁle in females when compared with males may also
contribute to narrowing disparity observations. Risk and
severity for adverse cardiovascular is associated with under-
lying cardiometabolic disease and risk proﬁle [25]. Recent
reportsindicateanarrowingofriskandco-morbidityburden
among females when compared to males. For example, while
obesity in the population as a whole has increased in the
US population from 1999 to 2008, this increase has been
more remarkable among males than females of all ages [26].
Females have been reported to engage in physical activity
at a slightly higher rate than males and have also been
reported to smoke less cigarettes than males [27]. Some
studies also report that females particularly younger females10 Cardiology Research and Practice
maybemoresensitizedthantheywereadecadeagoaboutthe
risk associated with cardiovascular disease. This factor may
inadvertentlybeassociatedwithfacilitatedcareinitiationand
improved in-hospital outcomes for females [28].
The relative lack of improvement in AMI mortality rates
among US males aged <55 years, over the last decade is
also worthy of note. As much as the sex disparity in AMI
mortality for persons <55 years needs to be bridged, it would
be prudent not to overlook young and middle-aged males
so that a midlife sex disparity unfavorable to males does not
develop in future years.
This study is subject to important limitations including,
the use of administrative data that extrapolates AMI occur-
rence by using ICD-9 coding for incident disease encounters.
Coding errors may over or underreport AMI incidence.
Observations of AMI incidence without documented proce-
dures recorded may be indicative of false AMI diagnosis in
the sample, since it is rare that AMI encounters will exclude
diagnostic or therapeutic risk assessment. This observed
phenomenonmayalsoindicatesecondaryreferralofpatients
to centers with more appropriate risk exploration and
stratiﬁcation capacity. Additionally, we could not control for
the diﬀerential inﬂuence of certain risk factors for adverse
cardiovascular disease outcomes like obesity, dyslipidemia
and smoking status using in-hospital administrative data.
In spite of these limitations, we believe this study demon-
strates a signiﬁcant reduction in AMI in-hospital mortality
trend from 1997 to 2006, and the most remarkable gain
was observed among young females aged <55 years when
compared to age-matched males. This study supports the
need for continued clinical and public health eﬀort aimed
at reducing any residual disparities in outcomes for females
when compared with males while improving the overall in-
hospital quality of care for AMI.
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